Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
MGI Tech Expands Partnership with Fiocruz to Accelerate Advances in Epidemiological Surveillance and Personalized Medicine in Brazil 2025-06-05 11:02
ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy 2025-06-05 06:01
Mabwell Receives NMPA Approval for Albipagrastim alfa for Injection (MAILISHENG) 2025-05-30 22:00
Dx&Vx Accelerates Development of Universal COVID-19 Vaccine 2025-05-29 21:03
Mabwell Announces Clinical Data of Multiple ADCs to be presented at 2025 ASCO Annual Meeting 2025-05-23 22:00
Dupixent approved in Singapore as the first-ever biologic medicine for patients with COPD 2025-05-14 10:30
THANARA: A Microbiome-Based Skincare Innovation Featuring 4P-Biotics Technology by AL-DNA 2025-05-09 10:00
DNV recognized as a Notified Body for Certification under In Vitro Diagnostic Regulation (IVDR) 2025-05-08 22:38
BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate 2025-05-08 20:30
The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China 2025-05-07 14:19
SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats 2025-05-06 20:00
INTREPID Alliance Releases New Report Highlighting Urgent Gaps in Antiviral Preparedness 2025-05-06 02:16
Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation 2025-05-02 21:00
Mabwell Releases 6 Study Results of Innovative Drugs and Platforms at the 2025 AACR Annual Meeting 2025-04-30 20:00
Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW) 2025-04-28 20:00
Patrick Tan appointed as Duke-NUS Dean to lead next era of medical innovation and education 2025-04-11 20:06
VCI BIOFUELS GROUP SIGNS DEFINITIVE MERGER AGREEMENT WITH INTERNATIONAL MEDIA ACQUISITION CORP. TO PUBLICLY LIST ON THE NASDAQ 2025-04-10 04:40
Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation 2025-04-09 21:00
Mabwell Announces NMPA Approval to Initiate Clinical Trial of novel B7-H3-targeting ADC for Advanced Solid Tumors in Combination with PD-1 Inhibitor 2025-04-02 22:00
Mabwell to Present results of 6 studies at the 2025 American Association for Cancer Research (AACR) Annual Meeting 2025-03-26 20:00